Core Viewpoint - Robbins LLP has announced a class action lawsuit on behalf of investors who purchased Concorde International Group, Ltd. (NASDAQ: CIGL) securities between April 21, 2025, and July 14, 2025, alleging that the company was involved in a fraudulent "pump-and-dump" scheme [1][2]. Allegations - The lawsuit claims that during the class period, Concorde failed to disclose critical information, including the existence of a fraudulent stock promotion scheme that involved misinformation on social media and impersonation of financial professionals [2]. - It is alleged that insiders used offshore accounts to facilitate the coordinated dumping of shares during a price inflation campaign, and that public statements from Concorde omitted any mention of false rumors and artificial trading activity that inflated the stock price [2]. - The complaint highlights that Concorde's share price surged from an initial public offering price of $4.00 to a peak of $31.06 without any fundamental news justifying such an increase, followed by an abrupt crash of approximately 80% to $5.66 on July 10, 2025 [3]. Current Situation - Following the crash, Concorde's share price has continued to decline, currently sitting at approximately $2.00 [3]. - Shareholders interested in participating in the class action or serving as lead plaintiff are encouraged to contact Robbins LLP for more information [4].

Core Viewpoint - Driven Brands Holdings Inc. is facing a class action lawsuit due to significant errors in its financial statements, which have led to a substantial drop in its stock price and potential losses for investors [2][3]. Financial Disclosures - On February 25, 2025, Driven Brands announced material errors in its consolidated financial statements dating back to 2023, necessitating a restatement of these financials [2]. - The company identified at least ten categories of errors, including inappropriate revenue recognition, unreconciled cash account differences, and overstatement of expenses [2]. Stock Performance - Following the announcement of these errors, Driven Brands' stock price fell by $5.01, or 30.2%, closing at $11.60 per share on February 25, 2026, which has adversely affected investors [2]. Lawsuit Details - The class action lawsuit alleges that the company made materially false and misleading statements and failed to disclose adverse facts about its business and operations during the class period from May 9, 2023, to February 24, 2026 [3][5]. - Specific allegations include errors in lease accounting, cash balance reporting, and improper revenue recognition, which misled investors regarding the company's financial health [3][5].

Core Viewpoint - Soleno Therapeutics, Inc. is facing a securities fraud lawsuit due to allegations of misleading statements and undisclosed risks related to its drug DCCR, which has resulted in significant stock price declines and investor losses [1][5]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased Soleno common stock between March 26, 2025, and November 4, 2026, with a deadline to file a lead plaintiff motion by May 5, 2026 [1][7]. - The lawsuit alleges that Soleno made materially false and misleading statements regarding the safety and efficacy of DCCR, particularly concerning serious adverse reactions reported by patients [5][6]. Group 2: Stock Price Impact - Following the release of a critical report by Scorpion Capital on August 15, 2025, Soleno's stock price fell by $9.27 per share, or 11.98%, closing at $68.09 on August 18, 2025 [3]. - After a patient death was disclosed on September 10, 2025, the stock price dropped by $13.49 per share, or 19.21%, closing at $56.72 on September 11, 2025 [3]. - On November 4, 2025, Soleno reported financial results indicating that the negative report had disrupted DCCR's launch, leading to a further decline of $16.98 per share, or 26.59%, closing at $46.87 on November 5, 2025 [4][5]. Group 3: Allegations Against Soleno - The lawsuit claims that Soleno's Phase 3 clinical trial for DCCR downplayed significant safety concerns, including issues related to excess fluid retention [6]. - It is alleged that the administration of DCCR posed greater safety risks than disclosed, leading to lower commercial viability and increased patient discontinuation rates [6].

RT 土澳大狮兄BroLeon | 🔶BNB | (@BroLeon)以后也别抱怨币安或者其他CEX频繁弹出验证了，因为现在如果他们自己不严格一点可能会出大血😂😂刚看到美国有几百人起诉币安资助“恐怖袭击”被驳回这个新闻，稍微搜了一下，发现这就是比较典型的律师商业化搞“蚂蚁吃象”的案例。原告律师把535 名原告、64 起袭击、多个组织、跨多年事件，全塞进一个超大型诉状里，这种打法本身就带有很强的规模化诉讼产品味道。在美国的法律机制里，原告律师很多时候按 contingency fee 做事，也就是先垫成本，赢了再抽成。所以他们很乐于去找原告人数多，被告有钱且社会情绪强的案子。一旦打赢了，律师们可以赚的盆满钵满。这次恐怖袭击受害者+币安就很符合条件。历史上BP Deepwater漏油门事件，BP赔了187亿美元，其中光是一笔联邦多区诉讼和解里，律师费就赚了6亿美金。大众柴油门事件，2016 年相关和解规模达到约 147 亿美元，律师申请费达到3.3亿美元。阿片药物案，2021 年围绕几家主要药企和分销商的全国性和解规模约 260 亿美元，如果按上限粗略算，理论上律师费池可能高达 39 亿美元。所以千万不能小看集体 ...

Core Viewpoint - Oracle Corporation is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its AI infrastructure strategy and its financial implications for the company [1]. Summary by Relevant Sections Class Action Details - The class period for the lawsuit is from June 12, 2025, to December 16, 2025 [1]. - Shareholders who purchased shares during this period are encouraged to contact The Gross Law Firm for potential lead plaintiff appointment [1]. Allegations Against Oracle - The complaint alleges that Oracle's AI infrastructure strategy would lead to significant increases in capital expenditures without corresponding near-term revenue growth [1]. - It is claimed that the increased spending poses serious risks to Oracle's debt and credit rating, free cash flow, and ability to fund projects [1]. - The representations made by Oracle regarding its business operations and prospects are alleged to be materially false and misleading or lacking a reasonable basis [1]. Next Steps for Shareholders - Shareholders are advised to register for the class action by April 6, 2026, to participate in the case without any cost or obligation [1]. - Upon registration, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case [1].

Core Viewpoint - A class action securities lawsuit has been filed against Klarna Group plc, alleging securities fraud related to its initial public offering (IPO) on September 10, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who purchased Klarna securities in connection with the IPO [2]. - The complaint alleges that defendants materially understated the risk of increased loss reserves shortly after the IPO, which they either knew or should have known [3]. - It is claimed that the public statements made by the defendants were materially false and misleading, and negligently prepared [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Klarna Group plc have until February 20, 2026, to request appointment as lead plaintiff [4]. - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [4]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5]. - The firm has over 70 employees dedicated to serving clients in complex securities litigation [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. due to allegations of misleading statements regarding the company's competitive position and performance, which have led to significant investor losses [2][4]. Group 1: Allegations and Misleading Statements - The complaint alleges that Avantor and its executives violated federal securities laws by making false and misleading statements about the company's competitive positioning and failing to disclose the negative impacts of increased competition [4]. - During an earnings call on July 26, 2024, the then CEO Michael Stubblefield assured investors of Avantor's strong competitive position, despite evidence suggesting otherwise [5]. - The company downplayed the effects of increased competition, claiming competitive advantages that were later proven to be overstated [5]. Group 2: Financial Performance and Stock Impact - On April 25, 2025, Avantor reported disappointing Q1 2025 results, cutting its guidance and attributing weak performance to increased competitive intensity, resulting in a stock price drop of over 16.5% [6]. - The company further reported a year-over-year decrease in net sales on August 1, 2025, and projected organic revenue growth of -2% to 0%, leading to another stock decline of more than 15% [7][8]. - In Q3 2025, Avantor reported a net loss of $712 million, primarily due to a non-cash goodwill impairment charge of $785 million, which was attributed to competitive pressures, causing the stock to drop over 23% [9][10].